ftInvstr
SYNCOMF · Healthcare ₹20.41 -4.13% Mkt Cap ₹1928 Cr

SYNCOMF

Healthcare Drug Manufacturers - Specialty & Generic
₹20.41
-4.13% today · 30d +54.97%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for SYNCOMF. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹126 Cr
+7.38% YoY
NET PROFIT
₹25 Cr
+57.71% YoY
OPM
25.52%
+7.76pp YoY
EPS
₹0.26
PE 22.52
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-47.6%, h2=-50.0%, h3=-48.9% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
SYNCOMF22.5219.0
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
77
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 90
Valuation REASONABLE 60
Growth STEADY 69
Profitability HIGH 85
Technicals NEUTRAL 68
Risk LOW 90
Key Stats
TTM PE
22.52
P/B
4.55
52W HIGH
₹22.59
OFF HIGH
-9.65%
DIV YIELD
0.49%
MKT CAP
₹1928 Cr
◉ Active Signals
MACDBullish0.4301
RSI(14)Bearish72.68
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SYNCOMF and at what entry.

Sign up freeSign in